Biblio

Export 52 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Title is U  [Clear All Filters]
2018
S. Baiardi, Capellari, S., Stella, A. Bartoletti, and Parchi, P., “Unusual Clinical Presentations Challenging the Early Clinical Diagnosis of Creutzfeldt-Jakob Disease.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1051-1065, 2018.
A. Wallin, Román, G. C., Esiri, M., Kettunen, P., Svensson, J., Paraskevas, G. P., and Kapaki, E., “Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1417-1441, 2018.
F. Yao, Hong, X., Li, S., Zhang, Y., Zhao, Q., Du, W., Wang, Y., and Ni, J., “Urine-Based Biomarkers for Alzheimer's Disease Identified Through Coupling Computational and Experimental Methods.”, J Alzheimers Dis, vol. 65, no. 2, pp. 421-431, 2018.
B. Bonnechère, Van Vooren, M., Bier, J. - C., De Breucker, S., Van Hove, O., Jan, S. Van Sint, Feipel, V., and Jansen, B., “The Use of Mobile Games to Assess Cognitive Function of Elderly with and without Cognitive Impairment.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1285-1293, 2018.
F. Segovia, Gómez-Río, M., Sánchez-Vañó, R., Górriz, J. Manuel, Ramírez, J., Triviño-Ibáñez, E., Carnero-Pardo, C., Martínez-Lozano, M. Dolores, and Sopena-Novales, P., “Usefulness of Dual-Point Amyloid PET Scans in Appropriate Use Criteria: A Multicenter Study.”, J Alzheimers Dis, vol. 65, no. 3, pp. 765-779, 2018.
K. R. Thomas, Edmonds, E. C., Eppig, J., Salmon, D. P., and Bondi, M. W., “Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 64, no. 1, pp. 195-204, 2018.
C. Lage, Suarez, A. Gonzalez, Pozueta, A., Riancho, J., Kazimierczak, M., Bravo, M., Bonilla, J. Jimenez, Torres, Mde Arcocha, Quirce, R., Banzo, I., Vázquez-Higuera, J. Luis, Rabinovici, G. D., Rodriguez-Rodriguez, E., and Sánchez-Juan, P., “Utility of Amyloid and FDG-PET in Clinical Practice: Differences Between Secondary and Tertiary Care Memory Units.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1025-1033, 2018.
Y. - F. Shea, Barker, W., Greig-Gusto, M. T., Loewenstein, D. A., DeKosky, S. T., and Duara, R., “Utility of Amyloid PET Scans in the Evaluation of Patients Presenting with Diverse Cognitive Complaints.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1599-1608, 2018.
T. Porter, Burnham, S. C., Milicic, L., Savage, G., Maruff, P., Lim, Y. Ying, Li, Q. - X., Ames, D., Masters, C. L., Rainey-Smith, S., Rowe, C. C., Salvado, O., Groth, D., Verdile, G., Villemagne, V. L., and Laws, S. M., “Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1193-1211, 2018.
A. Pons, LaMonica, H. M., Mowszowski, L., Köhler, S., Deckers, K., and Naismith, S. L., “Utility of the LIBRA Index in Relation to Cognitive Functioning in a Clinical Health Seeking Sample.”, J Alzheimers Dis, vol. 62, no. 1, pp. 373-384, 2018.
2019
P. Chatterjee, Elmi, M., Goozee, K., Shah, T., Sohrabi, H. R., Dias, C. B., Pedrini, S., Shen, K., Asih, P. R., Dave, P., Taddei, K., Vanderstichele, H., Zetterberg, H., Blennow, K., and Martins, R. N., “Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 3, pp. 775-783, 2019.
H. - S. Yang, Chhatwal, J. P., Xu, J., White, C. C., Hanseeuw, B., Rabin, J. S., Papp, K. V., Buckley, R. F., Schultz, A. P., Properzi, M. J., Gatchel, J. R., Amariglio, R. E., Donovan, N. J., Mormino, E. C., Hedden, T., Marshall, G. A., Rentz, D. M., Johnson, K. A., De Jager, P. L., and Sperling, R. A., “An UNC5C Allele Predicts Cognitive Decline and Hippocampal Atrophy in Clinically Normal Older Adults.”, J Alzheimers Dis, vol. 68, no. 3, pp. 1161-1170, 2019.
G. Paroni, Bisceglia, P., and Seripa, D., “Understanding the Amyloid Hypothesis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 68, no. 2, pp. 493-510, 2019.
Y. Wang, Wang, Y., Bharti, V., Zhou, H., Hoi, V., Tan, H., Wu, Z., Nagakannan, P., Eftekharpour, E., and Wang, J. - F., “Upregulation of Thioredoxin-Interacting Protein in Brain of Amyloid-β Protein Precursor/Presenilin 1 Transgenic Mice and Amyloid-β Treated Neuronal Cells.”, J Alzheimers Dis, vol. 72, no. 1, pp. 139-150, 2019.
2020
E. Tuzzi, Balla, D. Z., Loureiro, J. R. A., Neumann, M., Laske, C., Pohmann, R., Preische, O., Scheffler, K., and Hagberg, G. E., “Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1481-1499, 2020.
F. Clay, Howett, D., Fitzgerald, J., Fletcher, P., Chan, D., and Price, A., “Use of Immersive Virtual Reality in the Assessment and Treatment of Alzheimer's Disease: A Systematic Review.”, J Alzheimers Dis, vol. 75, no. 1, pp. 23-43, 2020.
S. Gill, Mouches, P., Hu, S., Rajashekar, D., MacMaster, F. P., Smith, E. E., Forkert, N. D., and Ismail, Z., “Using Machine Learning to Predict Dementia from Neuropsychiatric Symptom and Neuroimaging Data.”, J Alzheimers Dis, vol. 75, no. 1, pp. 277-288, 2020.
M. F. Bergeron, Landset, S., Zhou, X., Ding, T., Khoshgoftaar, T. M., Zhao, F., Du, B., Chen, X., Wang, X., Zhong, L., Liu, X., and J Ashford, W., “Utility of MemTrax and Machine Learning Modeling in Classification of Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 77, no. 4, pp. 1545-1558, 2020.
2021
S. Merighi, Battistello, E., Casetta, I., Gragnaniello, D., Poloni, T. Emanuele, Medici, V., Cirrincione, A., Varani, K., Vincenzi, F., Borea, P. Andrea, and Gessi, S., “Upregulation of Cortical A2A Adenosine Receptors Is Reflected in Platelets of Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 80, no. 3, pp. 1105-1117, 2021.
S. Chaudhary, Ashok, A., McDonald, D., Wise, A. S., Kritikos, A. E., Rana, N. A., Harding, C. V., and Singh, N., “Upregulation of Local Hepcidin Contributes to Iron Accumulation in Alzheimer's Disease Brains.”, J Alzheimers Dis, vol. 82, no. 4, 2021.
H. Zhang, D'Agostino, C., Forman, H. Jay, Cacciottolo, M., Thorwald, M., Mack, W. J., Liu, Q., Shkirkova, K., Lamorie-Foote, K., Sioutas, C., Pirhadi, M., Mack, W. Jean, Morgan, T. E., and Finch, C. E., “Urban Air Pollution Nanoparticles from Los Angeles: Recently Decreased Neurotoxicity.”, J Alzheimers Dis, vol. 82, no. 1, pp. 307-316, 2021.
2022
R. McGrath, Robinson-Lane, S. G., Klawitter, L., Rhee, Y., Hamm, J. M., McCourt, M. E., Parker, K., and Hackney, K. J., “Undiagnosed Dementia Is Associated with Poor Physical Function in Older Adults.”, J Alzheimers Dis, vol. 89, no. 2, pp. 473-482, 2022.
2023
K. Pushpa Tryphena, Anuradha, U., Kumar, R., Rajan, S., Srivastava, S., Singh, S. Bala, and Khatri, D. Kumar, “Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S187-S202, 2023.
A. Loughman, Adler, C. J., and Macpherson, H., “Unlocking Modifiable Risk Factors for Alzheimer's Disease: Does the Oral Microbiome Hold Some of the Keys?”, J Alzheimers Dis, vol. 92, no. 4, pp. 1111-1129, 2023.
S. Chand Basha, Ramaiah, M. Janaki, and Kosagisharaf, J. Rao, “Untangling the Role of TREM2 in Conjugation with Microglia in Neuronal Dysfunction: A Hypothesis on a Novel Pathway in the Pathophysiology of Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S319-S333, 2023.

Pages